CNSY — CERENOME, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1095981 ·
Last close
$1.86
Market Cap
—
52W High
$23.50
52W Low
$1.86
ADV30
85,926
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -9,057,000 | -9,006,000 | 14,030,000 | 2,366,000 | 8,567,000 |
| Mar 2026 | 0 | — | -7,119,000 | -6,946,000 | 19,916,000 | 3,022,000 | 7,955,000 |
| Dec 2025 | 0 | — | -5,742,000 | -5,713,000 | 16,325,000 | 4,256,000 | 12,329,000 |
| Sep 2025 | 0 | — | -4,482,000 | -4,423,000 | 18,670,000 | 13,289,000 | 13,616,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,841,000
Investing CF
$-12,945,000
Financing CF
$26,941,000
CapEx
$-882,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-31.55
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-522,811,000
Inventory
—
Receivables
$1,350,000
ST Investments
$12,092,000
EBIT TTM
$-8,853,000
Pretax Income TTM
$-11,931,000
Interest Exp TTM
$3,078,000
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -15,298,000 | -22,386,000 | 16,325,000 | 12,329,000 | 3,996,000 | -20,775,000 |
| Dec 2024 | 0 | -14,695,000 | -12,978,000 | 6,633,000 | 15,582,000 | -8,949,000 | -10,554,000 |
| Dec 2023 | 0 | -13,321,000 | -13,316,000 | 11,388,000 | 12,736,000 | -1,348,000 | -12,851,000 |
| Dec 2022 | 0 | -19,712,000 | -20,275,000 | 23,867,000 | 17,422,000 | 6,445,000 | -12,972,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $147.68B | $412.18 | — |
| MDT | Medtronic plc | $111.40B | $87.09 | — |
| SYK | STRYKER CORP | $106.93B | $278.77 | — |
| MMM | 3M CO | $86.89B | $168.49 | — |
| BSX | BOSTON SCIENTIFIC CORP | $63.59B | $43.88 | — |
News headlines (Yahoo Finance, 1h cache)
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
2026-09-30 11:30 · Yahoo
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
2026-09-25 11:30 · Yahoo
Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
2026-09-22 11:30 · Yahoo
Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
2026-09-16 11:30 · Yahoo
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
2026-09-10 11:15 · Yahoo
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
2026-08-20 11:30 · Yahoo
Cerenome Reports Second Quarter 2026 Financial Results and Business Update
2026-08-14 20:15 · Yahoo
Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
2026-08-13 11:30 · Yahoo
Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform
2026-08-06 11:30 · Yahoo
Cerenome Launches as an Integrated CNS Oncology Company
2026-07-31 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.